With funding from NIHR, the ATTC network aims to build upon its existing work, expand its reach, and integrate its outputs into standard practice. This will be delivered through a series of interconnected initiatives, detailed below, each addressing persistent barriers in the field.
- Clinical Trials Acceleration
- Training and Education
- Patient and Public Involvement and Engagement
- Patient Recruitment
- Data Collection and Use
- Logistics
The UK is a world leader in clinical research with 187 active advanced therapy trials, and with 9.5% of global ATMP trials having representation in the UK1. However, many more products are in development; further action is needed to ensure that the NHS can deliver advanced therapies to patients at scale across the UK and that the UK maintains its position as a globally attractive location for clinical research.